Literature and evidence database
Find the source, the model and the boundary.
Search source records connected to the product-family knowledge base. Filter by category, product, publication year, research type, study model and editorial evidence tier.
Product evidence maps
A focused source set for each product.
Search and filter
Evidence records
Narrow the records by product, year or study model. Open each source to check its results and limitations.
Bachem: peptide notation and terminal modifications
Bachem: peptide notation and terminal modifications. Accessed 2026-10-03.
Bachem: Quality Control of Amino Acids and Peptides
Bachem: Quality Control of Amino Acids and Peptides. Accessed 2026-10-05.
Original publication PMID 24791752
Checked 2026-10-06; original study, not NHD batch evidence.
Thermo Fisher: Peptide Design guide
Checked 2026-10-05; source scope is identified in the article.
Agilent: Five Tips for Chromatographic Integration
Agilent: Five Tips for Chromatographic Integration. Accessed 2026-10-05.
Original GHK-Cu fibroblast collagen study
Checked 2026-10-05; source scope is identified in the article.
Chen et al., Biomaterials Research (2025): Food-Derived Tripeptide–Copper Self-Healing Hydrogel for Infected Wound Healing
Original publication; reported findings apply to its study material and model. Checked 2026-10-04.
TGA finds inconsistent Melanotan II content
Official August 2026 laboratory-testing safety alert.
Glutathione for skin health: systematic review
Systematic review. 2024. PMID 39444151.
SCENESSE (afamelanotide) prescribing information
U.S. FDA label, revised 2024.
Clinical evaluation of a dual anti-wrinkle dissolving microneedle patch
Shin JY, et al. Ann Dermatol. 2024. PMID 39082657.
Glutathione biology and homeostasis
Review. 2023. PMID 36707132.
Clinical efficacy of a cosmetic dissolving microneedle patch
Combination-product study. 2019. PMID 31134751.
Analytical Procedures and Methods Validation for Drugs and Biologics
U.S. Food and Drug Administration. Guidance for Industry, July 2015.
Melanotan II systemic toxicity with rhabdomyolysis
Case report. 2012. PMID 23121206.
Effects of topical copper tripeptide complex on laser-resurfaced skin
Miller TR, et al. Archives of Facial Plastic Surgery. 2006. PMID 16847171.
Human pigmentation and pharmacokinetics of a synthetic melanotropin
Human study. 1997. PMID 9113347.
Certain Bulk Drug Substances That May Present Significant Safety Risks
U.S. FDA. Current compounding safety-information page.
Care and handling of peptides
Care and handling of peptides
Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate.
Ternary Cu(II) Complex with GHK Peptide and Cis-Urocanic Acid as a Potential Physiologically Functional Copper Chelate.
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds.
The Laccase-like Property of GHK-Cu and Its Applications in Colorimetric Sensing of Phenolic Compounds.
Peptide Isolation – Method Development Considerations
Peptide Isolation – Method Development Considerations
ICH Q2(R2): Validation of Analytical Procedures
Defines validation characteristics and distinguishes quantitative analytical purposes.
Research news reference — pubmed.ncbi.nlm.nih.gov — news-26
Research news reference — pubmed.ncbi.nlm.nih.gov — news-09
Primary publication — PubMed 26132941
ICH Q2(R2) Validation of Analytical Procedures
ICH Q2(R2) Validation of Analytical Procedures
ICH Q1A(R2) Stability Testing of New Drug Substances and Products
ICH Q1A(R2) Stability Testing of New Drug Substances and Products
Teaching reference — database.ich.org — ICH_Q2(R2)_Guideline_2023_1130_ErrorCorrection_2025.pdf
Editorial methodology
How records are classified
Records are deduplicated by source URL and linked to every relevant product family. Study type and model are inferred from the citation and editorial evidence label, then reviewed during content QA.
Read the full editorial, AI-assistance and correction policy →
Labels and databases supporting regulatory status, formulation or chemical identity.
Controlled trials, systematic reviews and other clinical records with population-specific interpretation.
Animal, cell, analytical and mechanistic records that cannot establish human outcomes.
Narrative reviews, registries and sponsor reports kept visibly distinct from peer-reviewed outcomes.
Use the records
